API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com/news-release/2021/06/21/2250101/0/en/Oyster-Point-Pharma-Announces-Enrollment-of-First-Subject-in-the-OLYMPIA-Phase-2-Clinical-Trial-of-OC-01-varenicline-Nasal-Spray-for-Patients-with-Neurotrophic-Keratopathy.html